- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01525108
A Home-based Blood Pressure Monitoring Program to Promote Better Management of Hypertension
A Home-based Blood Pressure Measurement Program in Hypertensive Patients to Promote Medications Adherence and Blood Pressure Status.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
Adherence to treatment is disappointingly low among patients with chronic health disorders especially after 6 month of initiating drug therapy. In hypertensive patients , as reported by WHO, 50% of non-adherence could be expected. Poor adherence to anti hypertensive medications results in increased morbidity, mortality and costs. One of the reasons that could implicate medications adherence can be attributed to seeing no physical sign of better controlling blood pressure. Self monitoring of blood pressure at home has been reported to improve patients adherence to their medications.
This study is a 2-arm randomized controlled trial. The investigators aim to evaluate the effect of home-based blood pressure measurement with an electronic device on medication adherence and blood pressure status.
One hundred ninety six hypertensive patients aged at least 18 years old are recruited in an ambulatory care setting and are evenly allocated to the study arms with balanced-block telephone randomization.
Appropriate medication is prescribed as preferred by the cardiologist (single daily dose medicines are recommended). Patients in both arms are followed for 24 weeks, each will be visited by the cardiologist four times during the study period. In each visit, patients' blood pressure will be measured twice by a nurse in the office.
In the intervention arm, electronic blood pressure device is provided for each patient and he/she will be trained to measure blood pressure at home once daily (same time each day). A logbook is also provided to document the daily blood pressure level.
Primary outcome of the study is the blood pressure measured at each office visit overtime. Medication adherence is measured by pill count method as the secondary outcome.
Studietype
Registrering (Faktiske)
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
Tehran, Iran, den islamske republikken
- Dr Mohagheghi's Office
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- Ambulatory patients older than 18
- Patients newly diagnosed as hypertension stage 1
- Patients previously on antihypertensive treatment but uncontrolled hypertension
- Patients not possessing electronic self blood pressure measurement device
- Patients with functional ability to use the device
Exclusion Criteria:
- Patients requiring two or more antihypertensive drugs at the start of the study
- Patients with secondary hypertension
- Patients cardiovascular comorbidities and other interfering medical conditions
- Patients with drug contraindication or documented drug allergy
- Patients with serum creatinine > 150 microliters
Withdrawal criteria:
- Inadequate therapeutic effect requiring an increase of more than 20% in pre-established number of visits
- Emergence of adverse drug reactions requiring cessation of medication
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Parallell tildeling
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
---|---|
Eksperimentell: Home-based blood pressure monitoring
|
Electronic blood pressure device is provided for patients and he/she will be trained to measure blood pressure at home once daily(same time each day).
A logbook is also provided to document the daily blood pressure level.
|
Aktiv komparator: Vanlig omsorg
|
Four visits to the physician's office at 4th, 12th, 24th week in the study period with usual advice giving practice of the staff.
At the end of the trial period, an electronic blood pressure device will be given to each patient in this arm.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Blood pressure-24 weeks
Tidsramme: Change from baseline(at the point of recruiting) blood pressure at 24 weeks.
|
Blood pressure is measured twice by trained nurses using hand-cuff device at the physician office.
(in Hg millimeter)
|
Change from baseline(at the point of recruiting) blood pressure at 24 weeks.
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
---|---|---|
Medication adherence-4 weeks
Tidsramme: Change from baseline(at the point of recruiting) medication adherence at 4 weeks
|
Change from baseline(at the point of recruiting) medication adherence at 4 weeks
|
|
Blood pressure- 4 weeks
Tidsramme: Change from baseline(at the point of recruiting) blood pressure at 4 weeks.
|
Change from baseline(at the point of recruiting) blood pressure at 4 weeks.
|
|
Blood pressure- 12 weeks
Tidsramme: Change from baseline(at the point of recruiting) blood pressure at 12 weeks.
|
Change from baseline(at the point of recruiting) blood pressure at 12 weeks.
|
|
Medication adherence- 12 weeks
Tidsramme: Change from baseline(at the point of recruiting) medication adherence at 12 weeks
|
Change from baseline(at the point of recruiting) medication adherence at 12 weeks
|
|
Medication adherence-24 weeks
Tidsramme: Change from baseline(at the point of recruiting) medication adherence at 24 weeks
|
Pill count method is employed.
At the time of each office visit, patients bring their medications with themselves and the researcher counts the unused pills.
Adherence is calculated as percentage of the pills used during previous weeks.
|
Change from baseline(at the point of recruiting) medication adherence at 24 weeks
|
Samarbeidspartnere og etterforskere
Samarbeidspartnere
Etterforskere
- Studiestol: Kheirollah Gholami, M.Sc,PharmD, Tehran University of Medical Sciences
- Studieleder: Zahra Jahangard-Rafsanjani, PharmD, Tehran University of Medical Sciences
- Hovedetterforsker: Arash Rashidian, M.D, Ph.D, Tehran University of Medical Sciences
Publikasjoner og nyttige lenker
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Anslag)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 90-04-156-15281
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Hypertensjon
-
University Hospital of CologneUkjentNAFLD; Hypertensjon, White-Coat Hypertension, Masked HypertensionTyskland
-
Karolinska InstitutetFullførtWhite Coat Hypertension
-
Clinical Hospital Centre ZagrebEuropean Society of HypertensionUkjentWhite Coat Hypertension | Blodtrykk | LivsstilsrisikoreduksjonIsrael, Hellas, Belgia, Tyskland, Armenia, Østerrike, Bulgaria, Kroatia, Tsjekkia, Estland, Italia, Libanon, Litauen, Nederland, Polen, Portugal, Romania, Serbia, Spania, Sverige, Ukraina, Storbritannia
-
Regional Hospital HolstebroFullførtSunn | White Coat Hypertension | Essensiell hypertensjonDanmark
-
Columbia UniversityAgency for Healthcare Research and Quality (AHRQ)Aktiv, ikke rekrutterendeWhite Coat Hypertension | Hypertensjon, viktigForente stater
-
University of Alabama at BirminghamTroy UniversityFullførtHypertensjon | Hypertensjon, motstandsdyktig mot konvensjonell terapi | Ukontrollert hypertensjon | Hypertensjon, hvit pelsForente stater
-
PD Dr. Grégoire WuerznerSwiss National Science FoundationFullførtHypertensjon | Overvekt | White Coat Hypertension | Resistent hypertensjonSveits
-
University Hospital, ToursFullførtPTFE-dekkede stenter versus nakne stenter i TIPS (Transjugulær Intra-hepatisk Porto-systemisk shunt)Cirrhotic Portal HypertensionFrankrike
-
Sun Yat-sen UniversityFullførtHepatocellulært karsinom (HCC) | Cirrhotic Portal HypertensionKina
Kliniske studier på Self monitoring of blood pressure
-
Ascensia Diabetes CareFullført
-
Tel Hai CollegeBar-Ilan University, IsraelFullført
-
Uskudar State HospitalFullført
-
Gruppo Italiano Malattie EMatologiche dell'AdultoFullførtAkutt promyelocytisk leukemiItalia
-
Azienda Ospedaliera Universitaria Integrata VeronaUkjentBukspyttkjertelkreft | Psykologisk stressItalia
-
Koç UniversityMarmara University; Sultan Abdulhamid Han Training and Research Hospital... og andre samarbeidspartnereRekruttering
-
SciensanoKU Leuven; University of Liege; Universiteit AntwerpenAktiv, ikke rekrutterendeCovid-19 | SARS-CoV-2-infeksjonBelgia
-
Sheba Medical CenterRekrutteringDatainnsamling | SpørreskjemaerIsrael
-
University of EdinburghNHS LothianAvsluttet